Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Behandlingsskolen Fortuna ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0%   Bankruptcy risk   24.1% 15.8% 11.8% 8.3% 4.1% 2.5% 6.5% 6.5%   Credit score (0-100)   4 12 19 29 48 62 37 37   Credit rating   B BB BB BB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   25,746 28,774 27,100 32,296 33,777 36,386 0.0 0.0   EBITDA   -568 -3,066 1,061 4,406 3,448 6,538 0.0 0.0   EBIT   -627 -3,183 836 4,151 3,238 6,404 0.0 0.0   Pre-tax profit (PTP)   -642.2 -3,200.2 816.8 4,092.5 3,333.0 6,868.5 0.0 0.0   Net earnings   -501.2 -2,496.9 637.0 3,183.0 2,599.2 5,349.8 0.0 0.0   Pre-tax profit without non-rec. items   -642 -3,200 817 4,093 3,333 6,869 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   136 499 500 354 307 1,256 0.0 0.0   Shareholders equity total   -1,033 -3,530 -2,893 290 2,890 8,239 8,189 8,189   Interest-bearing liabilities   33.3 4,386 2,423 43.4 69.0 51.0 0.0 0.0   Balance sheet total (assets)   2,014 7,010 4,714 5,128 7,898 13,478 8,189 8,189   Net Debt   -78.0 2,543 1,912 -1,716 -849 -373 -8,189 -8,189     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   25,746 28,774 27,100 32,296 33,777 36,386 0.0 0.0   Gross profit growth   9.7% 11.8% -5.8% 19.2% 4.6% 7.7% -100.0% 0.0%   Employees   52 61 47 50 51 49 0 0   Employee growth %   8.3% 17.3% -23.0% 6.4% 2.0% -3.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,014 7,010 4,714 5,128 7,898 13,478 8,189 8,189   Balance sheet change%   3.4% 248.0% -32.8% 8.8% 54.0% 70.7% -39.2% 0.0%   Added value   -568.1 -3,066.3 1,060.5 4,406.4 3,493.3 6,537.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   11 247 -223 -402 -258 815 -1,256 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -2.4% -11.1% 3.1% 12.9% 9.6% 17.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -22.7% -46.8% 9.2% 65.2% 51.2% 64.6% 0.0% 0.0%   ROI %   -183.4% -144.0% 22.1% 235.0% 202.5% 122.7% 0.0% 0.0%   ROE %   -25.3% -55.3% 10.9% 127.2% 163.5% 96.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -33.9% -33.5% -38.0% 5.7% 36.6% 61.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   13.7% -82.9% 180.3% -39.0% -24.6% -5.7% 0.0% 0.0%   Gearing %   -3.2% -124.3% -83.8% 14.9% 2.4% 0.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.6% 0.9% 0.6% 4.7% 2.1% 56.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.4 0.5 0.5 1.0 1.2 2.0 0.0 0.0   Current Ratio   0.4 0.5 0.5 1.0 1.2 2.0 0.0 0.0   Cash and cash equivalent   111.3 1,842.7 510.6 1,759.8 918.2 423.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,956.5 -4,816.7 -3,316.7 -63.3 989.4 5,011.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -11 -50 23 88 68 133 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -11 -50 23 88 68 133 0 0   EBIT / employee   -12 -52 18 83 63 131 0 0   Net earnings / employee   -10 -41 14 64 51 109 0 0